© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Infographic: 3 Key Regulatory Developments in January, 2018
The FDA and Commissioner Scott Gottlieb, MD, have made a number of announcements already in 2018. Here are 3 key regulatory developments that have taken place in the early days of January.
The FDA and Commissioner Scott Gottlieb, MD, have made a number of announcements already in 2018. Here are 3 key regulatory developments that have taken place in the early days of January.
Related Content:
